

BioTime is a biotechnology company focused on biomedical research and product development in regenerative medicine. Among its major competitors, BioTime is ranked in 10th place for NPS while Bristol Myers Squibb is 1st, and GlaxoSmithKline is 2nd.Their current market cap is $11.07M